These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2438936)

  • 1. Selection and validation of alpha-fetoprotein assay kits for the screening of Down syndrome.
    Knight GJ; Haddow J; Palomaki GE; Haddow JE
    Am J Obstet Gynecol; 1987 Jun; 156(6):1557-9. PubMed ID: 2438936
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-fetoprotein. ACOG Technical Bulletin number 154--April 1991.
    Int J Gynaecol Obstet; 1992 Jul; 38(3):241-7. PubMed ID: 1280604
    [No Abstract]   [Full Text] [Related]  

  • 3. Deregulation of screening for alpha-fetoprotein in pregnancy.
    Haddow JE; Milunsky A
    N Engl J Med; 1984 Jun; 310(25):1669-70. PubMed ID: 6203037
    [No Abstract]   [Full Text] [Related]  

  • 4. Prenatal screening for open neural tube defects and Down syndrome: three decades of progress.
    Wald NJ
    Prenat Diagn; 2010 Jul; 30(7):619-21. PubMed ID: 20572104
    [No Abstract]   [Full Text] [Related]  

  • 5. Maternal serum screening for neural tube defects and Down syndrome.
    Keith D
    Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964
    [No Abstract]   [Full Text] [Related]  

  • 6. Maternal serum alpha-fetoprotein screening in 1987.
    Simpson JL; Nadler HL
    Obstet Gynecol; 1987 Jan; 69(1):134-5. PubMed ID: 2432449
    [No Abstract]   [Full Text] [Related]  

  • 7. Current issues in maternal serum alpha-fetoprotein screening.
    Bock JL
    Am J Clin Pathol; 1992 Apr; 97(4):541-54. PubMed ID: 1372789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndrome.
    Macri JN; Anderson RW; Krantz DA; Larsen JW; Buchanan PD
    Am J Obstet Gynecol; 1996 Feb; 174(2):566-72. PubMed ID: 8623786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha-1-fetoprotein in the amniotic fluid and blood of pregnant women].
    Zizkovský V; Koubová J; Havranová M; Chudý D; Fuchs V
    Cesk Gynekol; 1988 Jun; 53(5):330-9. PubMed ID: 2457452
    [No Abstract]   [Full Text] [Related]  

  • 10. Benefits of maternal serum alpha-fetoprotein testing.
    Dyson RD
    Am Fam Physician; 1996 Nov; 54(6):1890, 1893. PubMed ID: 8900347
    [No Abstract]   [Full Text] [Related]  

  • 11. Prenatal screening for neural tube defects.
    Holtzman NA
    Pediatrics; 1983 Apr; 71(4):658-60. PubMed ID: 6188096
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-fetoprotein: an enhanced-sensitivity assay for neural tube defect and Down syndrome evaluation.
    Musto JD; Pizzolante JM; Chesarone VP; Sassi AM; Sane R
    Clin Chem; 1986 Jul; 32(7):1412. PubMed ID: 2424639
    [No Abstract]   [Full Text] [Related]  

  • 13. Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
    Haddow JE
    Semin Perinatol; 1990 Dec; 14(6):488-503. PubMed ID: 1706536
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of an enhanced luminescence assay for alpha-fetoprotein.
    John R; Henley R; Shankland D
    Clin Chem; 1986 Nov; 32(11):2066-9. PubMed ID: 2430734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Normal range of alpha-fetoprotein in amniotic fluid and maternal plasma].
    Monti E; Centini G; Landi D; Pecciarini L; Pasqui L; Severi FM
    Minerva Ginecol; 1987 May; 39(5):315-20. PubMed ID: 2442670
    [No Abstract]   [Full Text] [Related]  

  • 16. [The triple-serum test for detection of Down syndrome and neural tube defects; the problem of a risk assessment test].
    van den Boer-van den Berg JM; Dupuis HM
    Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1286-9. PubMed ID: 7688445
    [No Abstract]   [Full Text] [Related]  

  • 17. Maternal serum alpha-fetoprotein screening.
    Burton BK
    Pediatr Ann; 1989 Nov; 18(11):687-92, 694-7. PubMed ID: 2478951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and diagnosis of fetal neural tube defects, abdominal wall defects and Down's syndrome. With special reference to biochemical and ultrasound screening in the second trimester of pregnancy and to early amniocentesis.
    Jørgensen FS
    Dan Med Bull; 2001 Aug; 48(3):127-45. PubMed ID: 11556264
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serum analysis in pregnant women. Mass screening is an effective way to discover chromosome aberrations--arguments for and against].
    Kristoffersson U; Nørgaard-Pedersen B
    Lakartidningen; 1995 Mar; 92(12):1205-6, 1211-2. PubMed ID: 7535873
    [No Abstract]   [Full Text] [Related]  

  • 20. New uncertainties in prenatal screening for neural tube defect.
    Harris R; Read AP
    Br Med J (Clin Res Ed); 1981 May; 282(6274):1416-8. PubMed ID: 6164431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.